Erin Leigh Gilson
CIK: 0002126798
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCPC
BALCHEM CORP
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Gilson Erin Leigh
Gilson Erin Leigh (SEC CIK 0002126798) files insider reports with the SEC as Chief Accounting Officer of BALCHEM CORP (BCPC).
Signal8 holds 1 ownership filing by Gilson Erin Leigh, a Form 3, filed on Apr 7, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Gilson Erin Leigh's filings is in MONTVALE, NJ.
Other insiders filing for BALCHEM CORP (BCPC)
- van Gunsteren Job Leonard, SVP and GM, Specialty Products
- Reid Martin Luther, SVP Chief Supply Chain Officer
- Harris Theodore L, Chairman, President & CEO
- Graham George, SVP and Chief R&D Officer
- Backus William A., VP & Chief Accounting Officer
- Boned Frederic, SVP/GM, Human Nutri. & Health